Skip to Main Content

Author Details

Wenyi Wang
The University of Texas MD Anderson Cancer Center
2010
84
33
PMIDPaper TitleJournal TitlePublished Year
36909464Personalized Risk Prediction for Cancer Survivors: A Bayesian Semi-parametric Recurrent Event Model with Competing Outcomes.bioRxiv2023
37693464Validating risk prediction models for multiple primaries and competing cancer outcomes in families with Li-Fraumeni syndrome using clinically ascertained data at a single institute.medRxiv2023
37540752Multiomics analyses reveal <i>DARS1-AS1</i>/YBX1-controlled posttranscriptional circuits promoting glioblastoma tumorigenesis/radioresistance.Sci Adv2023
37604640<i>TP53</i> gain-of-function mutation modulates the immunosuppressive microenvironment in non-HPV-associated oral squamous cell carcinoma.J Immunother Cancer2023
37461467Accelerated somatic mutation calling for whole-genome and whole-exome sequencing data from heterogenous tumor samples.bioRxiv2023
37453101Association of Polygenic Score With Tumor Molecular Subtypes in Papillary Thyroid Carcinoma.J Clin Endocrinol Metab2023
37205631Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants.Cancer Res2023
35977347Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma.JCO Precis Oncol2022
35697807Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.Nat Biotechnol2022
35751806MuSE: A Novel Approach to Mutation Calling with Sample-Specific Error Modeling.Methods Mol Biol2022
35874475Protocol for establishing a protein-protein interaction network using tandem affinity purification followed by mass spectrometry in mammalian cells.STAR Protoc2022
32931023HepatoScore-14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk.Hepatology2021
33626321PAF remodels the DREAM complex to bypass cell quiescence and promote lung tumorigenesis.Mol Cell2021
32817165A pedigree-based prediction model identifies carriers of deleterious de novo mutations in families with Li-Fraumeni syndrome.Genome Res2020
32059873Induction of antitumor immunity in mice by the combination of nanoparticle-based photothermolysis and anti-PD-1 checkpoint inhibition.Nanomedicine2020
31782549Elucidation of WW domain ligand binding specificities in the Hippo pathway reveals STXBP4 as YAP inhibitor.EMBO J2020
31719101Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter Cohorts.Cancer Res2020
31719099Penetrance Estimates Over Time to First and Second Primary Cancer Diagnosis in Families with Li-Fraumeni Syndrome: A Single Institution Perspective.Cancer Res2020
33456641BAYESIAN VARIABLE SELECTION FOR SURVIVAL DATA USING INVERSE MOMENT PRIORS.Ann Appl Stat2020
33015524Systematic Assessment of Tumor Purity and Its Clinical Implications.JCO Precis Oncol2020
28629259Bayesian analysis of longitudinal dyadic data with informative missing data using a dyadic shared-parameter model.Stat Methods Med Res2019
31485091Bayesian Semiparametric Estimation of Cancer-specific Age-at-onset Penetrance with Application to Li-Fraumeni Syndrome.J Am Stat Assoc2019
30829413Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma.Am J Hematol2019
30469014Transcriptome Deconvolution of Heterogeneous Tumor Samples with Immune Infiltration.iScience2018
29891922SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity.Nat Commun2018
29862382Accurate RNA Sequencing From Formalin-Fixed Cancer Tissue To Represent High-Quality Transcriptome From Frozen Tissue.JCO Precis Oncol2018
30374053TMEM9 promotes intestinal tumorigenesis through vacuolar-ATPase-activated Wnt/β-catenin signalling.Nat Cell Biol2018
30361697Deregulation of CRAD-controlled cytoskeleton initiates mucinous colorectal cancer via β-catenin.Nat Cell Biol2018
27899618RNA-seq mixology: designing realistic control experiments to compare protocols and analysis methods.Nucleic Acids Res2017
28137790Estimating <i>TP53</i> Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPRO.Cancer Epidemiol Biomarkers Prev2017
28174230Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9-coupled Affinity Purification/Mass Spectrometry Analysis Revealed a Novel Role of Neurofibromin in mTOR Signaling.Mol Cell Proteomics2017
29097911MicroPET/CT Imaging of AXL Downregulation by HSP90 Inhibition in Triple-Negative Breast Cancer.Contrast Media Mol Imaging2017
29039124Recent progress in mass spectrometry proteomics for biomedical research.Sci China Life Sci2017
28723574Proteomic Analysis of the Human Tankyrase Protein Interaction Network Reveals Its Role in Pexophagy.Cell Rep2017
26999735LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress.Nat Cell Biol2016
26566882Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour.J Med Genet2016
27806300Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers.Cell Rep2016
27531557Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.Hepatology2016
27557938MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data.Genome Biol2016
27347765Hepatocellular Carcinoma: Intra-arterial Delivery of Doxorubicin-loaded Hollow Gold Nanospheres for Photothermal Ablation-Chemoembolization Therapy in Rats.Radiology2016
27346356FOXR2 Interacts with MYC to Promote Its Transcriptional Activities and Tumorigenesis.Cell Rep2016
27432908Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family.Mol Cell Proteomics2016
26740524Bayesian variable selection for binary outcomes in high-dimensional genomic studies using non-local priors.Bioinformatics2016
27037360Proteomic Analysis Reveals a Novel Mutator S (MutS) Partner Involved in Mismatch Repair Pathway.Mol Cell Proteomics2016
27009971LIG4 mediates Wnt signalling-induced radioresistance.Nat Commun2016
26847993Next-Generation Molecular Testing of Newborn Dried Blood Spots for Cystic Fibrosis.J Mol Diagn2016
26843124PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness.Nat Commun2016
25137225From pathways to networks: connecting dots by establishing protein-protein interaction networks in signaling pathways using affinity purification and mass spectrometry.Proteomics2015
26381235An ensemble approach to accurately detect somatic mutations using SomaticSeq.Genome Biol2015
26456820Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins.Cell Rep2015
  • 1 - 50 of 84

Recommended Authors

Washington University in St. Louis
Career Start Year 2017
Number of shared co-authors 8
British Columbia Cancer Research Institute
Career Start Year 2013
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 6
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 9
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year 2008
Number of shared co-authors 7
Brigham Young University
Career Start Year 2008
Number of shared co-authors 4
Chungnam National University
Career Start Year 2007
Number of shared co-authors 5
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 3
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 17
St. Jude Children's Research Hospital
Career Start Year 2006
Number of shared co-authors 2
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 9
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2006
Number of shared co-authors 1
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 3
Present address: Dxige Research Inc.
Career Start Year 2003
Number of shared co-authors 20
University of California
Career Start Year 2003
Number of shared co-authors 4
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 2
Washington University
Career Start Year 2003
Number of shared co-authors 4
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 13
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 1
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 3
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 13
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 0
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 7
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 1
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 24
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 9
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 5
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 3
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 7

Collaborators

The University of Texas MD Anderson Cancer Center
Co-authored papers 33
University of Texas MD Anderson Cancer Center
Co-authored papers 6
Stanford University
Co-authored papers 6
Georgetown University
Co-authored papers 6
Co-authored papers 5
the University of Texas MD Anderson Cancer Center
Co-authored papers 3
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 3
Clinical Genetics Branch, National Cancer Institute (NCI)
Co-authored papers 3
College of Horticulture, China Agricultural University
Co-authored papers 3
Stanford University
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Stanford University
Co-authored papers 2
Garvan Institute of Medical Research
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Dana-Farber Cancer Institute
Co-authored papers 2
Dana Farber Cancer Institute.
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Garvan Institute of Medical Research
Co-authored papers 2
University of Texas MD Anderson Cancer Center
Co-authored papers 2
Weill Medical College of Cornell University
Co-authored papers 2
Co-authored papers 2
University of California los angeles
Co-authored papers 2
Co-authored papers 2
Baylor College of Medicine
Co-authored papers 2
MD Anderson Cancer Center
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
the University of Texas MD Anderson Cancer Center
Co-authored papers 2
University of Texas MD Anderson Cancer Center
Co-authored papers 1
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 1